Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review

Published on Dec 4, 2020in Physics in Medicine and Biology2.883
· DOI :10.1088/1361-6560/ABAA28
Nolan Esplen3
Estimated H-index: 3
(UVic: University of Victoria),
Marc S. Mendonca24
Estimated H-index: 24
(IU: Indiana University),
Magdalena Bazalova-Carter12
Estimated H-index: 12
(UVic: University of Victoria)
Sources
Abstract
Ultrahigh dose-rate (>40 Gy/s) radiotherapy, or "FLASH" therapy, has gained significant momentum since the publication by Favaudon et al. in 2014, in which reduced normal tissue toxicity and similar tumor control for ultrahigh dose-rate radiotherapy compared to conventional radiotherapy was demonstrated in vivo. A number of subsequent studies from this and other groups investigating FLASH normal tissue protection followed shortly and the literature has been since been inundated with FLASH publications. Today, FLASH therapy has been considered by some as being capable of "revolutionizing radiotherapy". The goal of this review article is to present the current state of this intriguing radiotherapy technique. We namely review existing publications on FLASH radiotherapy (RT) in terms of its physical and biological aspects. In the physics section, ultrahigh dose-rate electron, photon and proton radiation sources with their beam delivery parameters are thoroughly discussed. Next, the benefits and drawbacks of equipment suitable for dosimetry in FLASH-RT, such as ionization chambers, radiochromic films, semiconductor detectors and alanine dosimeters, are presented. The biology section begins with a summary of the first in vitro high dose rate irradiations performed in the late 1960s and early 1970s and continues with a description of the recent normal and tumor tissue response studies performed with electron, photon and proton beams. The section is concluded with possible mechanistic explanations of the FLASH normal tissue protection effect (FLASH effect). The challenges of clinical application of FLASH-RT and its future prospects are critically discussed in the last section. Specifically, proposed treatment machines and treatment planning publications geared towards FLASH-RT are reviewed.
📖 Papers frequently viewed together
17 Citations
14 Citations
References251
Newest
#1Arash Darafsheh (WashU: Washington University in St. Louis)H-Index: 18
#2Yao Hao (WashU: Washington University in St. Louis)H-Index: 4
Last. Tianyu Zhao (WashU: Washington University in St. Louis)H-Index: 13
view all 10 authors...
PURPOSE It has been recently shown that radiotherapy at ultra-high dose rates (>40 Gy/s, FLASH) has a potential advantage in sparing healthy organs compared to that at conventional dose rates. The purpose of this work is to show the feasibility of proton FLASH irradiation using a synchrocyclotron as a first step toward implementing an experimental setup for pre-clinical studies. METHODS A clinical Mevion HYPERSCAN® synchrocyclotron was modified to deliver ultra-high dose rates. Pulse widths of p...
21 CitationsSource
#1Charles Fouillade (French Institute of Health and Medical Research)H-Index: 9
#2Sandra Curras-Alonso (Université Paris-Saclay)H-Index: 1
Last. Vincent Favaudon (French Institute of Health and Medical Research)H-Index: 28
view all 16 authors...
Purpose: One of the main limitations to anticancer radiotherapy lies in irreversible damage to healthy tissues located within the radiation field. "FLASH" irradiation at very high dose-rate is a new treatment modality that has been reported to specifically spare normal tissue from late radiation-induced toxicity in animal models and therefore could be a promising strategy to reduce treatment toxicity. Experimental Design: Lung responses to FLASH irradiation were investigated by qPCR, single-cell...
39 CitationsSource
#1Patricia van Marlen (VU: VU University Amsterdam)H-Index: 1
#2Max Dahele (VU: VU University Amsterdam)H-Index: 32
Last. Wilko F.A.R. Verbakel (VU: VU University Amsterdam)H-Index: 31
view all 6 authors...
Abstract Background Pre-clinical research into ultrahigh dose-rate (e.g. ≥40Gy/s) “FLASH”-radiotherapy suggests a decrease in side-effects compared to conventional irradiation, while maintaining tumor control. When FLASH is delivered using a scanning proton beam, tissue becomes subject to a spatially dependent range of dose-rates. This study systematically investigates dose-rate distributions and delivery times for proton FLASH-plans using stereotactic lung irradiation as the paradigm. Materials...
33 CitationsSource
#1S. Rossomme (UCL: Université catholique de Louvain)H-Index: 7
#2A. Delor (Cliniques Universitaires Saint-Luc)H-Index: 6
Last. Hugo PalmansH-Index: 31
view all 9 authors...
A new practical method to determine the ion recombination correction factor (alt;iagt;kalt;subagt;salt;/subagt;alt;/iagt;) for plane-parallel and Farmer-type cylindrical chambers in particle beams is investigated. a#13; Experimental data were acquired in passively scattered and scanned particle beams and compared with theoretical models developed by Boag and/or Jaffe. The new method, named the three-voltage linear method(3VL-method), is simple and consists of determining the saturation current u...
6 CitationsSource
Purpose Recent studies suggest that ultrahigh-dose-rate, “FLASH,” electron radiation therapy (RT) decreases normal tissue damage while maintaining tumor response compared with conventional dose rate RT. Here, we describe a novel RT apparatus that delivers FLASH proton RT (PRT) using double scattered protons with computed tomography guidance and provide the first report of proton FLASH RT-mediated normal tissue radioprotection. Methods and Materials Absolute dose was measured at multiple depths i...
87 CitationsSource
#1Gabriel Adrian (Lund University)H-Index: 4
#2Elise Konradsson (Lund University)H-Index: 2
Last. Kristoffer PeterssonH-Index: 14
view all 6 authors...
Objectives:Recent in vivo results have shown prominent tissue sparing effect of radiotherapy with ultra-high dose rates (FLASH) compared to conventional dose rates (CONV). Oxygen depletion has been...
44 CitationsSource
#1Joseph D. Wilson (University of Oxford)H-Index: 3
#2Ester M. Hammond (University of Oxford)H-Index: 45
Last. Kristoffer Petersson (University of Oxford)H-Index: 14
view all 4 authors...
Radiotherapy is a cornerstone of both curative and palliative cancer care. However, radiotherapy is severely limited by radiation-induced toxicities. If these toxicities could be reduced, a greater dose of radiation could be given therefore facilitating a better tumour response. Initial pre-clinical studies have shown that irradiation at dose rates far exceeding those currently used in clinical contexts reduce radiation-induced toxicities whilst maintaining an equivalent tumour response. This is...
94 CitationsSource
#1Magdalena Bazalova-Carter (UVic: University of Victoria)H-Index: 12
#2Nolan Esplen (UVic: University of Victoria)H-Index: 3
PURPOSE: By means of Monte Carlo (MC) simulations and indirect measurements, we have evaluated the maximum dose rates achievable with conventional x-ray tubes and related them to FLASH therapy dose rates of >40 Gy/s. METHODS: Monte Carlo models of two 160 kV x-ray tubes, the 3-kW MXR-160/22 and the 6-kW MXR-165, were built in the EGSnrc/BEAMnrc code. The dose rate in a water phantom placed against the x-ray tube surface, located at 3.7 and 3.5 cm from the focal spot for the MXR-160/22 and MXR-16...
14 CitationsSource
#1Bhanu Prasad Venkatesulu (University of Texas MD Anderson Cancer Center)H-Index: 7
#2Amrish Sharma (University of Texas MD Anderson Cancer Center)H-Index: 10
Last. Sunil KrishnanH-Index: 80
view all 10 authors...
Recent reports have shown that very high dose rate radiation (35–100 Gy/second) referred to as FLASH tends to spare the normal tissues while retaining the therapeutic effect on tumor. We undertook a series of experiments to assess if ultra-high dose rate of 35 Gy/second can spare the immune system in models of radiation induced lymphopenia. We compared the tumoricidal potency of ultra-high dose rate and conventional dose rate radiation using a classical clonogenic assay in murine pancreatic canc...
25 CitationsSource
2 CitationsSource
Cited By20
Newest
#1Roxane Oesterle (UNIL: University of Lausanne)
#2Patrik Gonçalves Jorge (UNIL: University of Lausanne)H-Index: 6
Last. Raphaël Moeckli (UNIL: University of Lausanne)H-Index: 19
view all 9 authors...
PURPOSE To implement and validate a beam current transformer as a passive monitoring device on a pulsed electron beam medical linear accelerator (LINAC) for ultra-high dose rate (UHDR) irradiations in the operational range of at least 3 Gy to improve dosimetric procedures currently in use for FLASH radiotherapy (FLASH-RT) studies. METHODS Two beam current transformers (BCTs) were placed at the exit of a medical LINAC capable of UHDR irradiations. The BCTs were validated as monitoring devices by ...
Source
#1Daniel D. Cecchi (UVic: University of Victoria)
Last. Magdalena Bazalova-Carter (UVic: University of Victoria)H-Index: 12
view all 8 authors...
PURPOSE To present an x-ray tube system capable of in vitro ultrahigh dose-rate (UHDR) irradiation of small < 0.3 mm samples and to characterize it by means of a plastic scintillation detector (PSD). METHODS AND MATERIALS A conventional x-ray tube was modified for the delivery of short UHDR irradiations. A beam shutter system with a sample holder was designed and installed in a close proximity of an x-ray tube window to enable <1 s irradiations at UHDR. The dosimetry was performed with a small 0...
Source
#1Jacinta Yap (University of Melbourne)
view all 3 authors...
The physical and clinical benefits of charged particle therapy (CPT) are well recognised and recent developments have led to the rapid emergence of facilities, resulting in wider adoption worldwide. Nonetheless, the availability of CPT and complete exploitation of dosimetric advantages are still limited by high facility costs and technological challenges. There are extensive ongoing efforts to improve upon these, which will lead to greater accessibility, superior delivery, and therefore better t...
#9J.M. Zentler (LLNL: Lawrence Livermore National Laboratory)H-Index: 2
Source
#1Theresa Suckert (HZDR: Helmholtz-Zentrum Dresden-Rossendorf)
#2Sindi Nexhipi (HZDR: Helmholtz-Zentrum Dresden-Rossendorf)
Last. Elke Beyreuther (HZDR: Helmholtz-Zentrum Dresden-Rossendorf)H-Index: 15
view all 0 authors...
The number of proton therapy centers worldwide are increasing steadily, with more than two million cancer patients treated so far. Despite this development, pending questions on proton radiobiology still call for basic and translational preclinical research. Open issues are the on-going discussion on an energy-dependent varying proton RBE (relative biological effectiveness), a better characterization of normal tissue side effects and combination treatments with drugs originally developed for pho...
Source
#1Yannick Poirier (UMB: University of Maryland, Baltimore)
#2Sina Mossahebi (UMB: University of Maryland, Baltimore)H-Index: 9
Last. Amit Sawant (UMB: University of Maryland, Baltimore)H-Index: 25
view all 8 authors...
Purpose null Due to their finite range, electrons are typically ignored when calculating shielding requirements in megavoltage-energy linear accelerator vaults. However, the assumption that 16 MeV electrons need not be considered does not hold when operated at FLASH-RT dose rates (~200× clinical dose rate), where dose rate from bremsstrahlung photons is an order of magnitude higher than that from an18 MV beam for which shielding was designed. We investigate the shielding and radiation protection...
Source
#1Minglei KangH-Index: 11
Last. Haibo LinH-Index: 11
view all 5 authors...
To quantitatively assess target and organs-at-risk (OAR) dose rate based on three proposed proton PBS dose rate metrics and study FLASH intensity-modulated proton therapy (IMPT) treatment planning using transmission beams. An in-house FLASH planning platform was developed to optimize transmission (shoot-through) plans for nine consecutive lung cancer patients previously planned with proton SBRT. Dose and dose rate calculation codes were developed to quantify three types of dose rate calculation ...
Source
#1Arash Darafsheh (WashU: Washington University in St. Louis)H-Index: 18
#2Yao Hao (WashU: Washington University in St. Louis)H-Index: 4
Last. Tianyu Zhao (WashU: Washington University in St. Louis)H-Index: 13
view all 8 authors...
PURPOSE The purpose of this work is to 1) demonstrate the feasibility of delivering a spread-out Bragg peak (SOBP) proton beam in ultra-high dose rate using a proton therapy synchrocyclotron as a major step toward realizing an experimental platform for preclinical studies, and 2) evaluate the response of four models of ionization chambers in such a radiation field. METHODS A clinical Mevion HYPERSCAN® synchrocyclotron was adjusted for ultra-high dose rate proton delivery. Protons with nominal en...
1 CitationsSource
#1Konrad Pawel Nesteruk (Paul Scherrer Institute)H-Index: 7
#2Michele Togno (Paul Scherrer Institute)H-Index: 2
Last. Serena Psoroulas (Paul Scherrer Institute)H-Index: 4
view all 9 authors...
PURPOSE The purpose of this work was to provide a flexible platform for FLASH research with protons by adapting a former clinical pencil beam scanning gantry to irradiations with ultra-high dose rates. METHODS PSI Gantry 1 treated patients until December 2018. We optimized the beamline parameters to transport the 250 MeV beam extracted from the PSI COMET accelerator to the treatment room, maximizing the transmission of beam intensity to the sample. We characterized a dose monitor on the gantry t...
2 CitationsSource
#1Martin A. Ebert (SCGH: Sir Charles Gairdner Hospital)H-Index: 26
#2Sarah L. Gulliford (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 23
Last. C. FiorinoH-Index: 7
view all 10 authors...
For decades, dose-volume information for segmented anatomy has provided the essential data for correlating radiotherapy dosimetry with treatment-induced complications. Dose-volume information has formed the basis for modelling those associations via normal tissue complication (NTCP) models and for driving treatment planning. Limitations to this approach have been identified. Many studies have emerged demonstrating that the incorporation of information describing the spatial nature of the dose di...
Source